Angiogenesis
Angiogenesis is the formation of new blood vessels. This process involves the migration, growth, and differentiation of endothelial cells, which line the inside wall of blood vessels. It is necessary
  • Catalog Number
  • CAS
  • Product Name
SALK10001
1032900-25-6
LDK378
Inquiry
SALK10002
1062368-24-4
LDN193189
Inquiry
SALK10003
877399-52-5
Crizotinib
Inquiry
SALK10004
356559-20-1
SB525334
Inquiry
SALK10005
301836-41-9
SB 431542
Inquiry
SALK10006
1256577-71-5
CH5424802 analog
Inquiry
SALK10007
1391712-60-9
CEP37440
Inquiry
SALK10008
452342-67-5
GW 788388
Inquiry
SALK10009
446859-33-2
RepSox
Inquiry
SALK10010
301836-43-1
D 4476
Inquiry
SALK10011
1627503-67-6
LDN214117
Inquiry
SALK10012
1472795-20-2
KRCA0008
Inquiry
SALK10013
1454846-35-5
Lorlatinib
Inquiry
SALK10014
1432597-26-6
LDN212854
Inquiry
SALK10015
1431985-92-0
K 02288
Inquiry
SALK10016
1356962-20-3
AZD3463
Inquiry
SALK10017
1365267-27-1
Ensartinib
Inquiry
SALK10018
694433-59-5
SB505124
Inquiry
SALK10019
1352608-82-2
Vactosertib
Inquiry
SALK10020
1256580-46-7
Alectinib
Inquiry
SALK10021
1206711-16-1
DMH1
Inquiry
SALK10022
1197958-12-5
AP26113
Inquiry
SALK10023
1197953-54-0
Brigatinib
Inquiry
SALK10024
1116235-97-2
GSK1838705A
Inquiry
SALK10025
1108743-60-7
Entrectinib
Inquiry
SALK10026
1097917-15-1
ASP 3026
Inquiry
SALK10027
1062368-62-0
LDN-193189 HCl
Inquiry
SALK10028
1062368-49-3
ML347
Inquiry
SALK10029
607737-87-1
A77-01
Inquiry
SALK10030
761438-38-4
ALK inhibitor 2
Inquiry
SALK10031
2137030-98-7
Ensartinib dihydrochloride
Inquiry
SALK10032
2351929-66-1
ALK-IN-5
Inquiry
SALK10033
1380575-43-8
LDK378 dihydrochloride
Inquiry
SALK10034
(-)-Cevimeline hydrochloride hemihydrate
Inquiry
SALK10035
113418-56-7
Wy 49051
Inquiry
SALK10036
879487-87-3
R-268712
Inquiry
SALK10037
868612-83-3
IN-1130
Inquiry
SALK10038
CEP-28122 mesylate salt (1022958-60-6 free base)
Inquiry
SALK10039
2244775-31-1
F-1
Inquiry
SALK10040
2170830-26-7
TGFBR1-IN-1
Inquiry
SALK10041
1352610-25-3
Vactosertib hydrochloride
Inquiry
SALK10042
1421373-99-0
AZ7550
Inquiry
SALK10043
AZ12601011
Inquiry
SALK10044
2254409-25-9
ALK2-IN-2
Inquiry
SALK10045
761439-42-3
TAE684
Inquiry
SALK10046
A 83-01 sodium salt
Inquiry
SALK10047
2230077-10-6
MS4077
Inquiry
SALK10048
1256589-74-8
Alectinib hydrochloride
Inquiry
SALK10049
1415560-69-8
Crizotinib hydrochloride
Inquiry
SALK10050
2141955-96-4
Blu-782
Inquiry
SALK10051
6601-66-7
6-Demethoxytangeretin
Inquiry
SALK10052
334951-90-5
BIBF0775
Inquiry
SALK10053
614749-78-9
SM 16
Inquiry
SALK10054
1802220-02-5
TPX0005
Inquiry
SALK10055
1357920-84-3
Belizatinib
Inquiry
SALK10056
1356962-34-9
HG-14-10-04
Inquiry
SALK10057
909910-43-6
ALK5 Inhibitor IV
Inquiry
SALK10058
1022958-60-6
CEP28122
Inquiry
SBCR10059
943319-70-8
Ponatinib
Inquiry
SBCR10060
152459-95-5
Imatinib
Inquiry
SBCR10061
220127-57-1
Imatinib mesylate
Inquiry
SBCR10062
641571-10-0
Nilotinib
Inquiry
SBCR10063
302962-49-8
Dasatinib
Inquiry
SBCR10064
380843-75-4
Bosutinib
Inquiry
SBCR10065
140674-76-6
Tyrphostin AG957
Inquiry
SBCR10066
497839-62-0
AEE788
Inquiry
SBCR10067
856243-80-6
Degrasyn
Inquiry
SBCR10068
839706-07-9
GNF7
Inquiry
SBCR10069
827318-97-8
Danusertib
Inquiry
SBCR10070
790299-79-5
Masitinib
Inquiry
SBCR10071
778277-15-9
GNF5
Inquiry
SBCR10072
778270-11-4
GNF2
Inquiry
SBCR10073
690206-97-4
ZM 306416
Inquiry
SBCR10074
6078-17-7
Berbamine dihydrochloride
Inquiry
SBCR10075
31430-18-9
Nocodazole
Inquiry
SBCR10076
477575-56-7
PHA665752
Inquiry
SBCR10077
861875-60-7
BAW2881
Inquiry
SBCR10078
260415-63-2
PD173955
Inquiry
SBCR10079
172889-26-8
PP1
Inquiry
SBCR10080
1421783-64-3
GZD824 Dimesylate
Inquiry